Avricore Health AVCRF
OTC AVCRF
$0.03 +0.00 (+0.00%)
At close: Aug 25, 2026 · 4:00 PM EDT

Avricore Health (AVCRF) Change in Account Payables (2022 - 2023)

Avricore Health (AVCRF) posted quarterly Change in Account Payables of -$86146.3 for Q4 2023, down 384.7% year-over-year from $30258.2 in Q4 2022, and down 139.82% quarter-over-quarter from $216364.6 in Q3 2023.

Avricore Health (AVCRF) Change in Account Payables (2022 - 2023) Analysis & Trends

Avricore Health (AVCRF) has reported Change in Account Payables for 2 consecutive years, with -$86146.3 the latest figure, recorded in Q4 2023.

  • In Q4 2023, Change in Account Payables fell 384.7% year-over-year to -$86146.3; the TTM figure through Dec 2023 stood at $304113.5 (up 58.69% YoY), while the FY2024 annual figure was -$115696.0, down 188.53% from the prior year.
  • Change in Account Payables declined to -$86146.3 in Q4 2023 per AVCRF's latest filing, from $216364.6 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $216364.6 in Q3 2023 and bottomed at -$86146.3 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -38.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 13.74 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 15.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -6.74 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 10.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 674,000.00
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -11.70 Mn
10 Avricore Health 3.04 Mn 3.01 Mn -6.20 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -86,146.33
Dec 31, 2023 -86,146.33
Sep 30, 2023 216,364.59
Sep 30, 2023 216,364.59
Dec 31, 2022 -17,772.96
Dec 31, 2022 -17,772.96
Sep 30, 2022 191,668.16
Sep 30, 2022 191,668.16